Cambridge Innovation Capital plc (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has participated in the £50.4 million Series B funding of Gyroscope Therapeutics, a company developing gene therapies and surgical delivery systems for retinal diseases, alongside lead investor Syncona Ltd.
Cambridge Innovation Capital
We enable visionaries to build global, category-leading companies
The Hauser Forum 3 Charles Babbage Road Cambridge
Post Code: CB3 0GT
Country: United Kingdom
Membership Type: Corporate 6-20